Suzhou Zelgen Biopharmaceuticals Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2026 is 44.23% vs 56.98% in Jun 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2026 is 115.98% vs -40.73% in Jun 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "300.00",
          "val2": "208.00",
          "chgp": "44.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-8.20",
          "val2": "-40.60",
          "chgp": "79.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "5.30",
          "val2": "6.70",
          "chgp": "-20.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "1.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "7.40",
          "val2": "-46.30",
          "chgp": "115.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-64.60%",
          "val2": "-264.30%",
          "chgp": "19.97%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 50.99% vs 37.93% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -9.85% vs 49.07% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "804.30",
          "val2": "532.70",
          "chgp": "50.99%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-191.00",
          "val2": "-162.70",
          "chgp": "-17.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "24.60",
          "val2": "29.10",
          "chgp": "-15.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.80",
          "val2": "3.90",
          "chgp": "-79.49%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-165.10",
          "val2": "-150.30",
          "chgp": "-9.85%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-306.70%",
          "val2": "-420.50%",
          "chgp": "11.38%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY

Jun'26

Jun'25

Change(%)

Net Sales

300.00

208.00

44.23%

Operating Profit (PBDIT) excl Other Income

-8.20

-40.60

79.80%

Interest

5.30

6.70

-20.90%

Exceptional Items

1.00

0.00

Consolidate Net Profit

7.40

-46.30

115.98%

Operating Profit Margin (Excl OI)

-64.60%

-264.30%

19.97%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2026 is 44.23% vs 56.98% in Jun 2025

Consolidated Net Profit

YoY Growth in quarter ended Jun 2026 is 115.98% vs -40.73% in Jun 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

804.30

532.70

50.99%

Operating Profit (PBDIT) excl Other Income

-191.00

-162.70

-17.39%

Interest

24.60

29.10

-15.46%

Exceptional Items

0.80

3.90

-79.49%

Consolidate Net Profit

-165.10

-150.30

-9.85%

Operating Profit Margin (Excl OI)

-306.70%

-420.50%

11.38%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 50.99% vs 37.93% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -9.85% vs 49.07% in Dec 2024

All Annual Results